| Literature DB >> 21925772 |
Julian de la Torre-Cisneros1, M Carmen Fariñas, Juan José Castón, José María Aguado, Sara Cantisán, Jordi Carratalá, Carlos Cervera, José Miguel Cisneros, Elisa Cordero, Maria G Crespo-Leiro, Jesús Fortún, Esteban Frauca, Joan Gavaldá, Salvador Gil-Vernet, Mercé Gurguí, Oscar Len, Carlos Lumbreras, María Ángeles Marcos, Pilar Martín-Dávila, Victor Monforte, Miguel Montejo, Asunción Moreno, Patricia Muñoz, David Navarro, Albert Pahissa, José Luis Pérez, Alberto Rodriguez-Bernot, José Rumbao, Rafael San Juan, Francisco Santos, Evaristo Varo, Felipe Zurbano.
Abstract
Cytomegalovirus infection remains a major complication of solid organ transplantation. In 2005 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, numerous publications have clarified or questioned the aspects covered in the previous document. These aspects include the situations and populations who must receive prophylaxis and its duration, the selection of the best diagnosis and monitoring technique and the best therapeutic strategy. For these reasons, we have developed new consensus guidelines to include the latest recommendations on post-transplant CMV management based on new evidence available.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21925772 DOI： 10.1016/j.eimc.2011.05.022
Source DB: PubMed Journal: Enferm Infecc Microbiol Clin ISSN： 0213-005X Impact factor: 1.731